Shortify
More news in less time
Home
/
Topic
#
sezary syndrome
1 story
Follow
#
antibody-drug conjugate
#
cancer drug
#
cash runway
#
innate pharma
#
iph4502
#
lacutamab
#
monalizumab
#
nasdaq ipha
#
phase iii trial
#
q2 earnings
#
sobi
Innate Pharma Q2 Earnings Highlights
Innate Pharma secures $75m Sobi deal for cancer drug.
Yahoo Finance · 1m
Load more stories
